Hormone therapy, osteoporosis treatments and hybrid health care with Risa Kagan, MD

S3E20: Brooke Faught, NP on sexual health, trauma-informed care, and the perks of meeting in-person

"The FDA did not raise any concern regarding the general approvability of elinzanetant in its correspondence," according to an anouncement from Bayer.

Lindsey Carr, Editor

FDA grants priority review to flibanserin for treating postmenopausal HSDD

In this episode of Pap Talk, we took you with us to the North American Menopause Society's recent Annual Meeting. Sexual health specialist Michael Krychman, MD, sat down with Brooke Faught, NP, to learn more about her work at the Women's Institute for Sexual Health, her role on the NAMS Planning Committee, and her tips for talking trauma with patients.

Listen

S3 E19: Alyssa Dweck, MD, on menopause products, her podcast, and more

The FDA has granted priority review to expand flibanserin (Addyi; Sprout Pharmaceuticals) use to postmenopausal women, potentially broadening access to treatment for hypoactive sexual desire disorder.

Lindsey Carr, Editor;Michael Krychman, MD

Younger age, lack of emotional support linked to depression in women with premature menopause

In this episode, Michael Krychman, MD, sat down with Alyssa Dweck, MD, gynecologist, and Bonafide medical advisor to catch up at this year's North American Menopause Society (NAMS) Annual Meeting.

Listen

Tirzepatide plus hormone therapy boosts weight loss in menopausal women

Nearly one-third of women with premature ovarian insufficiency experience depressive symptoms, according to a recent study.

FDA extends review period for Bayer's elinzanetant for vasomotor symptoms

Tirzepatide and menopause hormone therapy may significantly enhance weight loss and health outcomes in postmenopausal women.

Related Content

S3E20: Brooke Faught, NP on sexual health, trauma-informed care, and the perks of meeting in-person

"The FDA did not raise any concern regarding the general approvability of elinzanetant in its correspondence," according to an anouncement from Bayer.

Lindsey Carr, Editor

FDA grants priority review to flibanserin for treating postmenopausal HSDD

Listen

S3 E19: Alyssa Dweck, MD, on menopause products, her podcast, and more

Lindsey Carr, Editor;Michael Krychman, MD

Younger age, lack of emotional support linked to depression in women with premature menopause

In this episode, Michael Krychman, MD, sat down with Alyssa Dweck, MD, gynecologist, and Bonafide medical advisor to catch up at this year's North American Menopause Society (NAMS) Annual Meeting.

Listen

Tirzepatide plus hormone therapy boosts weight loss in menopausal women

Nearly one-third of women with premature ovarian insufficiency experience depressive symptoms, according to a recent study.